XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2016
Mar. 31, 2016
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Related-Party Transactions (Textual) [Abstract]            
Revenue from related parties     $ 199,074 $ 371,120    
Collaborative agreement, amended amount     13,500,000      
Collaborative agreement, awarded exercised amount     3,300,000      
Prepaid balance     76,000      
Revenue under collaborative research and development arrangements with affiliated entities            
Related-Party Transactions (Textual) [Abstract]            
Revenue from related parties     8,842 49,949    
Director            
Related-Party Transactions (Textual) [Abstract]            
Accounts receivable     3,500,000     $ 2,600,000
Expenses to reimburse   $ 3,100,000   $ 1,900,000    
Term   5 years   2 years    
Awarded amount $ 6,100,000          
Contra-research and development expense     1,500,000 $ 230,000    
Operating expenses related to affiliated entity     181,000 $ 318,000    
Accounts payable/accrued liabilities     1,400,000     548,000
Deferred grant funding, from affiliate     38,000      
The Wistar Institute            
Related-Party Transactions (Textual) [Abstract]            
Awarded amount         $ 10,700,000  
Awarded option amount     6,000,000      
Plumbline Life Sciences            
Related-Party Transactions (Textual) [Abstract]            
Accounts receivable     $ 34,000     $ 25,000
Plumbline Life Sciences | Available-for-sale Securities            
Related-Party Transactions (Textual) [Abstract]            
Investment owned (in shares)     597,808      
Ownership percentage     18.70%